The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. - Wikidata - awgldk - TriplyDB

The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.

The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.

http://www.wikidata.org/entity/Q42984320

about

Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines Evidence for hepatitis C viral infection in patients with primary hepatocellular carcinoma Hepatitis C virus (HCV) and hepatitis B virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection.Acute hepatitis C virus (HCV) infection in chronic carriers of hepatitis B virus (HBV): the impact of underlying active HBV replication on persistence of HCV infection and antibody responses to HCV Regulation of Hepatitis B Virus Replication by the Phosphatidylinositol 3-Kinase-Akt Signal Transduction Pathway Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells Molecular mechanisms underlying occult hepatitis B virus infection.Identification of diagnostic peptide regions that distinguish Zika virus from related mosquito-borne Flaviviruses An overview of triple infection with hepatitis B, C and D viruses.Hematologic disorders associated with hepatitis C virus infection and their management.Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection The influence of host factors on the natural history of chronic hepatitis C viral infections.Seropositivity and coinfection of hepatitis B and C among patients seeking hospital care in Islamabad, Pakistan Antineutrophil antibody: a test for autoimmune primary sclerosing cholangitis in childhood?Current pharmacotherapy for hepatitis B infection.Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique.Hepatitis B virus and hepatitis C virus dual infection.High prevalence of hepatitis C in Egyptian patients with chronic liver disease Current Concepts of HBV/HCV Coinfection: Coexistence, but Not Necessarily in Harmony.The impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infection.Management of chronic hepatitis B in patients from special populations Frequency of HIV and HCV Co-Infections in Chronic HBV Patients Referred to Taleghani Hospital, Tehran, Iran from 2006 to 2010.Replication Inhibition of Hepatitis B Virus and Hepatitis C Virus in Co-Infected Patients in Chinese Population.Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus Comparison of Helicobacter bilis-Associated Protein Expression in Huh7 Cells Harbouring HCV Replicon and in Replicon-Cured Cells Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated Non-Hodgkin Lymphoma Patients: A Large Cohort Retrospective Study.Prevalence and determinants of antibodies to hepatitis C virus and markers for hepatitis B virus infection in patients with HIV infection in Aquitaine. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.Hepatitis C: progress and problems.Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment.Current therapy for hepatitis C or D or immunodeficiency virus concurrent infection with chronic hepatitis B.MicroRNA-122 as a predictor of HBsAg seroclearance in hepatitis B and C dual infected patients treated with interferon and ribavirin Treatment of HBV/HCV coinfection.Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection.Multiple infections and cancer: implications in epidemiology.Potential risk of HBV reactivation in patients with resolved HBV infection undergoing direct-acting antiviral treatment for HCV.Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.The spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management.Post-transplant recurrent hepatitis B viral liver disease. Viral-burden, steatoviral, and fibroviral hepatitis B.

P2860

Q24815355-3700D8F5-19F2-4EC3-970E-2F36C2982486 Q27000080-D9389474-FCD5-4040-96AB-D11864740BC9 Q27469317-76D128BF-7D99-4D16-9042-EBBB56C0E22F Q27472769-5AEF0EF5-D38B-41A3-A198-190864AE18DB Q27477956-B0701B0A-3FFB-455B-9161-39BF7C8393C5 Q27481454-9ED6C4F9-F673-4575-9C47-DCD30671B1A2 Q27486067-AE57F14B-33F8-464B-A256-3C4B1F553925 Q27686923-CE28D8EB-4BC5-4D55-AA87-31A61344BCF9 Q30145545-D8938BBA-E2C6-4F40-BC56-9121635E045D Q30485092-75DD7D7B-AA87-4C57-AA41-E1C4E27E104D Q33349378-D21708C5-7C05-4E29-A373-C28AF589C0BB Q33674042-E52B151F-7791-4B46-9C09-825B8AB4404A Q33801341-07A6489B-F927-4077-91FE-E2B2072F9583 Q33890847-B6D2A796-5EED-4F00-A02E-CA11902CCB77 Q34375536-D75D5791-DC8A-41E6-A1D9-8F9F0D1659D9 Q34390231-20F86DC0-477B-450B-85AA-D4D992EA10B4 Q34396552-0F6F595F-4082-4D98-B520-84946599DE60 Q34404975-B74A8187-93F7-4CA9-A7A5-6664422A8020 Q34408632-69BC1366-B382-4894-B3D8-A9C40EC5235C Q34502980-BC7C98C0-83A0-4FA1-9959-AE837867199D Q35590977-79D29494-E785-45B0-9651-5FDB37B2FB98 Q35664183-B8795318-B79F-4242-826D-4F9B0DC13CDF Q35764225-E8249445-4BCC-4C61-8CAC-0C68AF485B2D Q35793834-CA62A8E1-55BF-4B31-9E0B-12BE8DAFC879 Q35833159-7440BE5F-7498-4802-82D4-50D1F0D26528 Q36147887-E1D5150F-1B16-4797-AC73-BDD93924AEB6 Q36195013-FA7D5738-2581-4AAB-A294-60A56FA34296 Q36599918-24F15B3C-CEA9-42CD-B9A6-8BC92F463646 Q36642065-4F4E41DA-1D20-44BB-91C1-98A7F1FD471B Q37060330-6F41168B-49D3-4F04-8A52-9AD15E4A210D Q37132382-2E61147B-AF20-4033-A3A2-9C00D1B88210 Q37278249-685F7ED5-EBCD-4F83-9C24-A57E82007B08 Q37281927-212F70F1-0047-4129-A2D3-F85DF9EB9557 Q37694558-5BD0E1FD-5CAF-4084-B9EB-26A02B66F443 Q37855732-3FBD4767-9E4F-4A84-871D-5E8652235F6C Q38126931-57C51DF7-62D3-4364-A696-4B83555BC170 Q38724160-A8D03612-E1D0-438D-937D-F0C5C9464BA4 Q38805093-C27166A5-5A02-42BC-A0EB-74E9B550A5FD Q42746527-0486F3AE-0B6D-47A8-B5DD-B484C26F7574 Q42755608-85DCB469-02F0-4788-9EC5-FD73DF0FC7ED

P2860

The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.

http://www.wikidata.org/entity/Q42984320

description

1991 nî lūn-bûn

@nan

1991年の論文

@ja

1991年論文

@yue

1991年論文

@zh-hant

1991年論文

@zh-hk

1991年論文

@zh-mo

1991年論文

@zh-tw

1991年论文

@wuu

1991年论文

@zh

1991年论文

@zh-cn

name

The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.

@en

The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.

@nl

type

label

The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.

@en

The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.

@nl

prefLabel

The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.

@en

The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.

@nl

P1433

Q42984320-35CBE5FF-3F35-4AF9-BF15-ED6D962F3F3B

P1476

Q42984320-8D49F5D6-8481-42EA-ABCE-81DA597B83B2

P2093

Q42984320-0CB1005A-017E-476C-9FFB-5E632C4FDE5B

Q42984320-5C90EC0E-2E98-490A-9FFB-77E2B4927A83

Q42984320-C44458F3-317C-40B3-8131-5B67BDD531CF

Q42984320-DD7B77FF-A888-46D6-A5FA-FF48CD098C7B

Q42984320-F25139A8-5722-4FDD-A080-033AD40B88BF

P2860

Q42984320-83E71967-D7F9-410E-9641-C1994946E148

Q42984320-A6D3BF7B-E8C2-4433-8603-AE738C4BFE5A

P304

Q42984320-3A7DB058-6372-43DC-B569-96097D4FD34D

P31

Q42984320-D5280F63-2B8F-4169-8EA6-6A40169F79F0

P356

Q42984320-59A548ED-A8CF-43B4-A85C-053464E72FB5

P407

Q42984320-1307695C-2558-4378-B388-A46A30FFDE15

P433

Q42984320-56117566-1D80-4424-81F7-033F807EF467

P478

Q42984320-138AD915-5590-4445-BF8B-34D174441DFE

P577

Q42984320-1DE97A6F-F29C-4C30-BDE4-D371C0ED91BC

P698

Q42984320-4DA40962-32B5-4741-A5F1-05B4EE056E0E

P921

Q42984320-93B968B5-13F6-4925-881E-FFD404C27B9A

P356

P1433

P1476

The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.

@en

P2093

Banks SM

http://www.w3.org/2001/XMLSchema#string

Di Bisceglie AM

http://www.w3.org/2001/XMLSchema#string

Fong TL

http://www.w3.org/2001/XMLSchema#string

Hoofnagle JH

http://www.w3.org/2001/XMLSchema#string

Waggoner JG

http://www.w3.org/2001/XMLSchema#string

P2860

Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood.

Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study.

P304

64-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.1840140111

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

1991-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1648540

http://www.w3.org/2001/XMLSchema#string

P921